Clindamycin

Back to search

Molecule Structure

Scientific Name

Clindamycin

Description of the Drug

Clindamycin is a lincosamide antibiotic used to treat serious infections caused by susceptible anaerobic, streptococcal, staphylococcal, and pneumococcal bacteria.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01190

Brand Name(s)

Antirobe, Cleocin, Cleocin T, Sobelin

Company Owner(s)

Mylan Pharmaceuticals Inc, Lannett Co Inc, Micro Labs Ltd, Watson Laboratories Inc, Lannett Holdings Inc, Cosette Pharmaceuticals Inc, Epic Pharma Llc, Pfizer Inc, Pharmacia And Upjohn Co, Sun Pharmaceutical Industries Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Bacterial 70S ribosome PROTEIN NUCLEIC-ACID COMPLEX INHIBITOR CHEMBL2363135

Unichem Links

SureChEMBL SCHEMBL3154
DrugBank DB01190
PubChem: Thomson Pharma 14905082 14880545
PubChem 446598
Nikkaji J9.300I
PDBe CLY
EPA CompTox Dashboard DTXSID2022836
DrugCentral 678
Brenda 6919
ChemicalBook CB4399999
Guide to Pharmacology 10607
GSRS 56a5959c-6a5f-4bb1-bd3a-f2d296887091
rxnorm CLINDAMYCIN HYDROCHLORIDE CLINDAMYCIN ANTIROBE
ZINC ZINC000004038341